To the best of our knowledge, this is the first time that survivin, hTERT, CK-7 and TTF-1 tumor-related mRNA markers have been used in combination to detect CTCs of advanced lung adenocarcinoma patients. The gene discussed is BIRC5; the disease is lung adenocarcinoma.